Epidemiology and Incidence: The Scope of the Problem and Risk Factors for Development of Venous Thromboembolism

Critical Care Clinics

Volumn 27, Issue 4, 2011, Pages 907-932

  Stein, Paul D ^a,b   Matta, Fadi ^a,b  

^a ST MARY MERCY HOSPITAL   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Epidemiology; Incidence; Pulmonary embolism; Venous thromboembolism

Indexed keywords

ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR 5 LEIDEN; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8C; ESTROGEN; GESTAGEN; ORAL CONTRACEPTIVE AGENT; TAMOXIFEN;

AFRICAN AMERICAN; AGE; ANTIPHOSPHOLIPID SYNDROME; ATTITUDE TO HEALTH; AVIATION; BED REST; BEHCET DISEASE; BODY HEIGHT; BODY MASS; BUERGER DISEASE; CARDIOVASCULAR RISK; CENTRAL VENOUS CATHETER; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONGESTIVE HEART FAILURE; DEEP VEIN THROMBOSIS; DEMOGRAPHY; DIABETES MELLITUS; DYSFIBRINOGENEMIA; ENTERITIS; ENVIRONMENTAL FACTOR; EUROPEAN AMERICAN; FATALITY; GENE MUTATION; GENETIC ASSOCIATION; HEALTH BELIEF; HEART FAILURE; HEMATOLOGIC DISEASE; HEPARIN INDUCED THROMBOCYTOPENIA; HEREDITY; HORMONE SUBSTITUTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERCOAGULABLE SYNDROME; HYPOTHYROIDISM; IMMOBILIZATION; INCIDENCE; LIFESTYLE; LIMB INJURY; LIVER DISEASE; LUNG EMBOLISM; MORTALITY; MYELOPROLIFERATIVE DISORDER; NEOPLASM; NEPHROTIC SYNDROME; OBESITY; PARALYSIS; PARESIS; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PREGNANCY; PREVALENCE; PRIORITY JOURNAL; RACE DIFFERENCE; REVIEW; RHEUMATOID ARTHRITIS; SEASONAL VARIATION; SEX DIFFERENCE; SICKLE CELL ANEMIA; SOCIAL STATUS; STROKE; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOPHILIA; TRAVEL; UNITED STATES; UPPER EXTREMITY DEEP VEIN THROMBOSIS; VARICOSIS; VENOUS THROMBOEMBOLISM; WINTER;

AGE FACTORS; HUMANS; INCIDENCE; PREVALENCE; RISK FACTORS; SEX FACTORS; UNITED STATES; VENOUS THROMBOEMBOLISM;

EID: 82755189983     PISSN: 07490704     EISSN: 15578232     Source Type: Journal    
DOI: 10.1016/j.ccc.2011.09.006     Document Type: Review

References (183)

1. Giuntini C., DiRicco G., Marini C., et al. Pulmonary embolism: epidemiology. Chest 1995, 107(Suppl):3S-9S.
2. Stein P.D., Matta F. Acute pulmonary embolism. Curr Prob Cardiol 2010, 35:314-376.
3. DeMonaco N.A., Dang Q., Kapoor W.N., et al. Pulmonary embolism incidence is increasing with use of spiral computed tomography. Am J Med 2008, 121:611-617.
4. Heit J.A., Silverstein M.D., Mohr D.N., et al. Predictors of survival after deep vein thrombosis and pulmonary embolism: a population-based, cohort study. Arch Intern Med 1999, 159:445-453.
5. Kahn S.R., Shrier I., Julian J.A., et al. Determinants and time course of the postthrombotic syndrome after acute deep venous thrombosis. Ann Intern Med 2008, 149:698-707.
6. Brandjes D.P., Büller H.R., Heijboer H., et al. Randomized trial of effect of compression stockings in patients with symptomatic proximal-vein thrombosis. Lancet 1997, 349:759-762.
7. Ginsberg J.S., Hirsh J., Julian J., et al. Prevention and treatment of postphlebitic syndrome: results of a 3-part study. Arch Intern Med 2001, 161:2105-2109.
8. Partsch H., Kaulich M., Mayer W. Immediate mobilisation in acute vein thrombosis reduces post-thrombotic syndrome. Int Angiol 2004, 23:206-212.
9. Prandoni P., Lensing A.W., Prins M.H., et al. Below-knee elastic compression stockings to prevent the post-thrombotic syndrome: a randomized, controlled trial. Ann Intern Med 2004, 141:249-256.
10. Aschwanden M., Jeanneret C., Koller M.T., et al. Effect of prolonged treatment with compression stockings to prevent post-thrombotic sequelae: a randomized controlled trial. J Vasc Surg 2008, 47:1015-1021.
11. Kearon C., Kahn S.R., Agnelli G., et al. American College of Chest Physicians. Antithrombotic therapy for venous thromboembolic disease: American College of chest physicians evidence-based clinical practice guidelines (8th edition). Chest 2008, 133:454S-545.
12. Palevsky H.I. Pulmonary hypertension and thromboembolic disease in women. Cardiovasc Clin 1989, 19:267-283.
13. Bernstein D., Goupey S., Schonberg S.K. Pulmonary embolism in adolescents. AJDC 1986, 140:667-671.
14. Coon W. Epidemiology of venous thromboembolism. Ann Surg 1977, 186:149-164.
15. Coon W.W., Willis P.W., Keller J.B. Venous thrombosis and other venous disease in the Tecumseh Community Study. Circulation 1973, 48:839-846.
16. Breckenridge R.T., Ralnoff O.D. Pulmonary embolism and unexpected death in supposedly normal persons. N Engl J Med 1964, 270:298-299.
17. Stein P.D., Hull R.D., Patel K.C., et al. Venous thromboembolic disease: comparison of the diagnostic process in men and women. Arch Intern Med 2003, 163:1689-1694.
18. Anderson F.A., Wheeler H.B., Goldberg R.J., et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT study. Arch Intern Med 1991, 151:933-938.
19. Ferrari E., Baudouy M., Cerboni P., et al. Clinical epidemiology of venous thromboembolic disease. Results of a French multicentre registry. Eur Heart J 1997, 18:685-691.
20. Lilienfeld D.E., Godbold J.H., Burke G.L., et al. Hospitalization and case fatality for pulmonary embolism in the twin cities: 1979-1984. Am Heart J 1990, 120:392-395.
21. Silverstein M.D., Heit J.A., Mohr D.N., et al. Trends in the incidence of deep vein thrombosis and pulmonary embolism. A 25-year population-based study. Arch Intern Med 1998, 158:585-593.
22. Stein P.D., Huang H.-L., Afzal A., et al. Incidence of acute pulmonary embolism in a general hospital: relation to age, sex, and race. Chest 1999, 116:909-913.
23. Stein P.D., Patel K.C., Kalra N.K., et al. Estimated incidence of acute pulmonary embolism in a community/teaching general hospital. Chest 2002, 121:802-805.
24. Kniffin W.D., Baron J.A., Barrett J., et al. The epidemiology of diagnosed pulmonary embolism and deep venous thrombosis in the elderly. Arch Intern Med 1994, 154:861-866.
25. Karwinski B., Svendsen E. Comparison of clinical and postmortem diagnosis of pulmonary embolism. J Clin Pathol 1989, 42:135-139.
26. Goldhaber S.Z., Savage D.D., Garrison R.J., et al. Risk factors for pulmonary embolism. The Framingham Study. Am J Med 1983, 74:1023-1028.
27. Quinn D.A., Thompson B.T., Terrin M.L., et al. A prospective investigation of pulmonary embolism in women and men. JAMA 1992, 268:1689-1696.
28. Stein P.D., Patel K.C., Kalra N.K., et al. Deep venous thrombosis in a general hospital. Chest 2002, 122:960-962.
29. Stein P.D., Hull R.D., Patel K.C., et al. Venous thromboembolic disease: comparison of the diagnostic process in blacks and whites. Arch Intern Med 2003, 163:1843-1848.
30. The unequal burden of cancer: an assessment of NIH research and programs for ethnic minorities and the medically underserved 1999, 19. National Academy Press, Washington, DC. M.A. Haynes, B.D. Smedley (Eds.).
31. Stein P.D., Kayali F., Olson R.E., et al. Pulmonary thromboembolism in Asian-Pacific Islanders in the United States: analysis of data from the National Hospital Discharge Survey and the United States Bureau of the Census. Am J Med 2004, 116:435-442.
32. White R.H. The epidemiology of venous thromboembolism. Circulation 2003, 107:I4-I8.
33. Svensson P.J., Dahlback B. Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 1994, 330:517-522.
34. Franco R.F., Reitsma P.H. Genetic risk factors of venous thrombosis. Hum Genet 2001, 109:369-384.
35. Ridker P.M., Miletich J.P., Hennekens C.H., et al. Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening. JAMA 1997, 277:1305-1307.
36. Rees D.C., Cox M., Clegg J.B. World distribution of factor V Leiden. Lancet 1995, 346:1133-1134.
37. Gregg J.P., Yamane A.J., Grody W.W. Prevalence of the factor V-Leiden mutation in four distinct American ethnic populations. Am J Med Genet 1997, 73:334-336.
38. Iso H., Folsom A.R., Wu K.K., et al. Hemostatic variables in Japanese and Caucasian men. Plasma fibrinogen, factor VIIc, factor VIIIc, and von Willebrand factor and their relations to cardiovascular disease risk factors. Am J Epidemiol 1989, 130:925-934.
39. Takahashi H., Echizen H. Pharmacogenetics of CYP2C9 and interindividual variability in anticoagulant response to warfarin. Pharmacogenomics J 2003, 3:202-214.
40. Yamaguchi T. Optimal intensity of warfarin therapy for secondary prevention of stroke in patients with nonvalvular atrial fibrillation: a multicenter, prospective, randomized trial. Stroke 2000, 31:817-821.
41. Matsuyama K., Matsumoto M., Sugita T., et al. Anticoagulant therapy in Japanese patients with mechanical mitral valves. Circulation 2002, 66:668-670.
42. Stein P.D., Kayali F., Olson R.E., et al. Pulmonary thromboembolism in American Indians and Alaskan Natives. Arch Intern Med 2004, 164:1804-1806.
43. Hooper W.C., Holman R.C., Heit J.A., et al. Venous thrombembolism hospitalizations among American Indians and Alaska Natives. Thromb Res 2003, 108:273-278.
44. Stein P.D., Hull R.D., Kayali F., et al. Venous thromboembolism according to age: the impact of an aging population. Arch Intern Med 2004, 164:2260-2265.
45. Stein P.D., Kayali F., Olson R.E. Incidence of pulmonary thromboembolism in infants and children. J Pediatr 2004, 145:563-565.
46. Andrew M., David M., Adams M., et al. Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE. Blood 1994, 83:1251-1257.
47. Bernstein D., Coupey S., Schonberg S.K. Pulmonary embolism in adolescents. Am J Dis Child 1986, 140:667-671.
48. Oral contraceptives, venous thrombosis, and varicose veins. J R Coll Gen Pract 1978, 28:393-399. Royal College of General Practitioners' Oral Contraception Study.
49. David M., Andrew M. Venous thromboembolic complications in children. J Pediatr 1993, 123:337-346.
50. Schmidt B., Andrew M. Neonatal thrombosis: report of a prospective Canadian and international registry. Pediatrics 1995, 96:939-943.
51. Wise R.C., Todd J.K. Spontaneous, lower-extremity venous thrombosis in children. Am J Dis Child 1973, 126:766-769.
52. Nuss R., Hays T., Manco-Johnson M. Childhood thrombosis. Pediatrics 1995, 96:291-294.
53. Stein P.D., Kayali F., Olson R.E. Analysis of occurrence of venous thromboembolic disease in the four seasons. Am J Cardiol 2004, 93:511-513.
54. Stein P.D., Kayali F., Olson R.E. Regional differences in rates of diagnosis and mortality of pulmonary thromboembolism. Am J Cardiol 2004, 93:1194-1197.
55. Klatsky A.L., Armstrong M.A., Poggi J. Risk of pulmonary embolism and/or deep venous thrombosis in Asian-Americans. Am J Cardiol 2000, 85:1334-1337.
56. White R.H., Zhou H., Romano P.S. Incidence of idiopathic deep venous thrombosis and secondary thromboembolism among ethnic groups in California. Ann Intern Med 1998, 128:737-740.
57. Horlander K.T., Mannino D.M., Leeper K.V. Pulmonary embolism mortality in the United States, 1979-1998: an analysis using multiple-cause mortality data. Arch Intern Med 2003, 163:1711-1717.
58. Attems J., Arbes S., Bohm G., et al. The clinical diagnostic accuracy rate regarding the immediate cause of death in a hospitalized geriatric population; an autopsy study of 1594 patients. Wien Med Wochenschr 2004, 154:159-162.
59. Lilienfeld D.E. Decreasing mortality from pulmonary embolism in the United States, 1979-1996. Int J Epidemiol 2000, 29:465-469.
60. Byrne J.J. Phlebitis: a study of 748 cases at the Boston City Hospital. N Engl J Med 1955, 253:579-586.
61. Hermann R.E., Davis J.H., Holden W.D. Pulmonary embolism: a clinical and pathologic study with emphasis on the effect of prophylactic therapy with anticoagulants. Am J Surg 1961, 102:19-28.
62. Collins R., Scrimgeour A., Yusuf S., et al. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery. N Engl J Med 1988, 318:1162-1173.
63. Stein P.D., Henry J.W., Relyea B. Untreated patients with pulmonary embolism: outcome, clinical and laboratory assessment. Chest 1995, 107:931-935.
64. Stein P.D., Kayali F., Olson R.E. Estimated case fatality rate of pulmonary embolism, 1979-1998. Am J Cardiol 2004, 93:1197-1199.
65. Carson J.L., Kelley M.A., Duff A., et al. The clinical course of pulmonary embolism. N Engl J Med 1992, 326:1240-1245.
66. Stein P.D., Henry J.W. Prevalence of acute pulmonary embolism among patients in a general hospital and at autopsy. Chest 1995, 108:978-981.
67. The Columbus Investigators Low-molecular-weight heparin in the treatment of patients with venous thromboembolism. N Engl J Med 1997, 337:657-662.
68. Simonneau G., Sors H., Charbonnier B., et al. A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism. The THESSE Study Group. N Engl J Med 1997, 337:663-669.
69. Stein P.D., Beemath A., Matta F., et al. Clinical characteristics of patient with acute pulmonary embolism: data from PIOPED II. Am J Med 2007, 120:871-879.
70. Stein P.D., Terrin M.L., Hales C.A., et al. Clinical, laboratory, roentgenographic and electrocardiographic findings in patients with acute pulmonary embolism and no pre-existing cardiac or pulmonary disease. Chest 1991, 100:598-603.
71. Heit J.A., Silverstein M.D., Mohr D.N., et al. The epidemiology of venous thromboembolism in the community. Thromb Haemost 2001, 86:452-463.
72. Anderson F.A., Wheeler H.B., Goldberg R.J., et al. The prevalence of risk factors for venous thromboembolism among hospital patients. Arch Intern Med 1992, 152:1660-1664.
73. Hedley A.A., Ogden C.L., Johnson C.L., et al. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA 2004, 291:2847-2850.
74. Goldhaber S.Z., Grodstein F., Stampfer M.J., et al. A prospective study of risk factors for pulmonary embolism in women. JAMA 1997, 277:642-645.
75. Abdollahi M., Cushman M., Rosendaal F.R. Obesity: risk of venous thrombosis and the interaction with coagulation factor levels and oral contraceptive use. Thromb Haemost 2003, 89:493-498.
76. Coon W.W., Coller F.A. Some epidemiologic considerations of thromboembolism. Surg Gynecol Obstet 1959, 109:487-501.
77. Basili S., Pacini G., Guagnano M.T., et al. Insulin resistance as a determinant of platelet activation in obese women. J Am Coll Cardiol 2006, 48:2531-2538.
78. Hansson P.O., Eriksson H., Welin L., et al. Smoking and abdominal obesity: risk factors for venous thromboembolism among middle-aged men: "the study of men born in 1913". Arch Intern Med 1999, 159:1886-1890.
79. Samama M.M. An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study. Arch Intern Med 2000, 160:3415-3420.
80. Kabrhel C., Varraso R., Goldhaber S.Z., et al. Prospective study of BMI and the risk of pulmonary embolism in women. Obesity (Silver Spring) 2009, 17:2040-2046.
81. Heit J.A., Silverstein M.D., Mohr D.N., et al. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med 2000, 160:809-815.
82. Public Health Service, National Center for Health Statistics National Hospital Discharge Survey 1979-2006 Multi-year Public-Use Data File Documentation US Department of Health and Human Services, Accessed April 28, 2010. http://www.cdc.gov/nchs/about/major/hdasd/nhds.htm.
83. Stein P.D., Beemath A., Olson R.E. Obesity as a risk factor in venous thromboembolism. Am J Med 2005, 118:978-980.
84. Farmer R.D., Lawrenson R.A., Todd J.C., et al. A comparison of the risks of venous thromboembolic disease in association with different combined oral contraceptives. Br J Clin Pharmacol 2000, 49:580-590.
85. Pannaciulli N., De Mitrio V., Marino R., et al. Effect of glucose tolerance status on PAI-1 plasma levels in overweight and obese subjects. Obes Res 2002, 10:717-725.
86. Juhan-Vague I., Alessi M.C., Mavri A., et al. Plasminogen activator inhibitor-1, inflammation, obesity, insulin resistance and vascular risk. J Thromb Haemost 2003, 1:1575-1579.
87. De Pergola G., Pannacciulli N. Coagulation and fibrinolysis abnormalities in obesity. J Endocrinol Invest 2002, 25:899-904.
88. Mertens I., Van Gaal L.F. Obesity, haemostasis and the fibrinolytic system. Obes Rev 2002, 3:85-101.
89. Bara L., Nicaud V., Tiret L., et al. Expression of a paternal history of premature myocardial infarction on fibrinogen, factor VIIC and PAI-1 in European offspring-the EARS study. European Atherosclerosis Research Study Group. Thromb Haemost 1994, 71:434-440.
90. Rosengren A., Fredén M., Hansson P.O., et al. Psychosocial factors and venous thromboembolism: a long-term follow-up study of Swedish men. J Thromb Haemost 2008, 6:558-564.
91. Glynn R.J., Rosner B. Comparison of risk factors for the competing risks of coronary heart disease, stroke, and venous thromboembolism. Am J Epidemiol 2005, 162:975-982.
92. Homans J. Thrombosis of the deep leg veins due to prolonged sitting. N Engl J Med 1954, 250:148-149.
93. Symington I.S., Stack B.H. Pulmonary thromboembolism after travel. Br J Dis Chest 1977, 71:138-140.
94. Tardy B., Page Y., Zeni F., et al. Phlebitis following travel. Presse Med 1993, 22:811-814.
95. Simpson K. Shelter deaths from pulmonary embolism. Lancet 1940, 2:744.
96. Cruickshank J.M., Gorlin R., Jennett B. Air travel and thrombotic episodes: the economy class syndrome. Lancet 1988, 2:497-498.
97. Collins J. Thromboembolic disease related to air travel: what you need to know. Semin Roentgenol 2005, 40:1-2.
98. Hertzberg S.R., Roy S., Hollis G., et al. Acute symptomatic pulmonary embolism associated with long haul air travel to Sydney. Vasc Med 2003, 8:21-23.
99. Perez-Rodriguez E., Jimenez D., Diaz G., et al. Incidence of air travel-related pulmonary embolism at the Madrid-Barajas airport. Arch Intern Med 2003, 163:2766-2770.
100. Hughes R.J., Hopkins R.J., Hill S., et al. Frequency of venous thromboembolism in low to moderate risk long distance air travellers: the New Zealand Air Traveller's Thrombosis (NZATT) study. Lancet 2003, 362:2039-2044.
101. Cogo A., Bernardi E., Prandoni P., et al. Acquired risk factors for deep-vein thrombosis in symptomatic outpatients. Arch Intern Med 1994, 154:164-168.
102. Lewis M.A. The epidemiology of oral contraceptive use: a critical review of the studies on oral contraceptives and the health of young women. Am J Obstet Gynecol 1998, 179:1086-1097.
103. Realini J.P., Goldzieher J.W. Oral contraceptives and cardiovascular disease: a critique of the epidemiologic studies. Am J Obstet Gynecol 1985, 152:729-798.
104. Vandenbroucke J.P., Rosing J., BloemenkampK W., et al. Oral contraceptives and the risk of venous thrombosis. N Engl J Med 2001, 344:1527-1535.
105. Gerstman B.B., Piper J.M., Tomita D.K., et al. Oral contraceptive estrogen dose and the risk of deep venous thromboembolic disease. Am J Epidemiol 1991, 133:32-37.
106. Lidegaard O., Edstrom B., Kreiner S. Oral contraceptives and venous thromboembolism. A case-control study. Contraception 1998, 57:291-301.
107. Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study. Lancet 1995, 346:1575-1582. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.
108. Helmrich S.P., Rosenberg L., Kaufman D.W., et al. Venous thromboembolism in relation to oral contraceptive use. Obstet Gynecol 1987, 69:91-95.
109. Pomp E.R., le Cessie S., Rosendaal F.R., et al. Risk of venous thrombosis: obesity and its joint effect with oral contraceptive use and prothrombotic mutations. Br J Haemotol 2007, 139:289-296.
110. Lidegaard O., Edstrom B., Kreiner S. Oral contraceptives and venous thromboembolism: a five-year national case-control study. Contraception 2002, 65:187-196.
111. Nightingale A.L., Lawrenson R.A., Simpson E.L., et al. The effects of age, body mass index, smoking and general health on the risk of venous thromboembolism in users of combined oral contraceptives. Eur J Contracept Reprod Healthcare 2000, 5:265-274.
112. Decensi A., Maisonneuve P., Rotmensz N., et al. Italian Tamoxifen Study Group. Effect of tamoxifen on venous thromboembolic events in a breast cancer prevention trial. Circulation 2005, 111:650-656.
113. Duggan C., Marriott K., Edwards R., et al. Inherited and acquired risk factors for venous thromboembolic disease among women taking tamoxifen to prevent breast cancer. J Clin Oncol 2003, 21:3588-3593.
114. Meier C.R., Jick H. Tamoxifen and risk of idiopathic venous thromboembolism. Br J Clin Pharmacol 1998, 45:608-612.
115. Daly E., Vessey M.P., Hawkins M.M., et al. Risk of venous thromboembolism in users of hormone replacement therapy. Lancet 1996, 348:977-980.
116. Jick H., Derby L.E., Myers M.W., et al. Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogens. Lancet 1996, 348:981-983.
117. Grodstein F., Stampfer M.J., Goldhaber S.Z., et al. Prospective study of exogenous hormones and risk of pulmonary embolism in women. Lancet 1996, 348:983-987.
118. Perez Gutthann S., García Rodriguez L.A., Castellsague J., et al. Hormone replacement therapy and risk of venous thromboembolism: population based case-control study. BMJ 1997, 314:796-800.
119. Varas-Lorenzo C., García-Rodriguez L., Cattaruzzi C., et al. Hormone replacement therapy and the risk of hospitalization for venous thromboembolism: a population-based study in southern Europe. Am J Epidemiol 1998, 147:387-390.
120. Grady D., Wenger N.K., Herrington D., et al. Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The Heart and Estrogen/progestin Replacement Study. Ann Intern Med 2000, 132:689-696.
121. Peverill R.E. Hormone therapy and venous thromboembolism. Best Pract Res Clin Endocrinol Metab 2003, 17:149-164.
122. Greaves M. Antiphospholipid antibodies and thrombosis. Lancet 1999, 353:1348-1353.
123. Levine J.S., Branch D.W., Rauch J. The antiphospholipid syndrome. N Engl J Med 2002, 346:752-763.
124. Asherson R.A., Khamashta M.A., Ordi-Ros J., et al. The "primary" antiphospholipid syndrome: major clinical and serological features. Medicine (Baltimore) 1989, 68:366-374.
125. Alarcon-Segovia D., Perez-Vazquez M.E., Villa A.R., et al. Preliminary classification criteria for the antiphospholipid syndrome within systemic lupus erythematosus. Semin Arthritis Rheum 1992, 21:275-286.
126. Vianna J.L., Khamashta M.A., Ordi-Ros J., et al. Comparison of the primary and secondary antiphospholipid syndrome: a European Multicenter Study of 114 patients. Am J Med 1994, 96:3-9.
127. Stein P.D., Hull R.D., Matta F., et al. Incidence of thrombocytopenia in hospitalized patients with venous thromboembolism. Am J Med 2009, 122:919-930.
128. Brick W., Burgess R., Faguet G.B. Dysfibrinogenemia. WebMD Accessed March 19, 2010. http://www.webmd.com.
129. Shively B.K. Deep venous thrombosis prophylaxis in patients with heart disease. Curr Cardiol Rep 2001, 3:56-62.
130. Isnard R., Komajda M. Thromboembolism in heart failure, old ideas and new challenges. Eur J Heart Fail 2001, 3:265-269.
131. Jafri S.M., Ozawa T., Mammen E., et al. Platelet function, thrombin and fibrinolytic activity in patients with heart failure. Eur Heart J 1993, 14:205-212.
132. Dries D.L., Rosenberg Y.D., Waclawiw M.A., et al. Ejection fraction and risk of thromboembolic events in patients with systolic dysfunction and sinus rhythm: evidence for gender differences in the studies of left ventricular dysfunction trials. J Am Coll Cardiol 1997, 29:1074-1080.
133. Kyrle P.A., Korninger C., Gossinger H., et al. Prevention of arterial and pulmonary embolism by oral anticoagulants in patients with dilated cardiomyopathy. Thromb Haemost 1985, 54:521-523.
134. Nordström M., Lindblad B., Bergqvist D., et al. A prospective study of the incidence of deep-vein thrombosis within a defined urban population. J Intern Med 1992, 232:155-160.
135. Segal J.P., Harvey W.P., Gurel T. Diagnosis and treatment of primary myocardial disease. Circulation 1965, 32:837-844.
136. Dunkman W.B., Johnson G.R., Carson P.E., et al. Incidence of thromboembolic events in congestive heart failure. The V-HeFT VA Cooperative Studies Group. Circulation 1993, 87(Suppl 6):VI94-VI101.
137. Kinsey D., White P. Fever in congestive heart failure. Arch Intern Med 1940, 65:163-170.
138. Roberts W.C., Siegel R.J., McManus B.M. Idiopathic dilated cardiomyopathy: analysis of 152 necropsy patients. Am J Cardiol 1987, 60:1340-1355.
139. Beemath A., Stein P.D., Skaf E., et al. Risk of venous thromboembolism in patients hospitalized with heart failure. Am J Cardiol 2006, 98:793-795.
140. Howell M.D., Geraci J.M., Knowlton A.A. Congestive heart failure and outpatient risk of venous thromboembolism: a retrospective, case-control study. J Clin Epidemiol 2001, 54:810-866.
141. Beemath A., Skaf E., Stein P.D. Pulmonary embolism as a cause of death in adults who died with heart failure. Am J Cardiol 2006, 98:1073-1075.
142. Mispelaere D., Glerant J.C., Audebert M., et al. Pulmonary embolism and sibilant types of chronic obstructive pulmonary disease decompensations. Rev Mal Respir 2002, 19:415-423.
143. Tillie-Leblond I., Marquette C.H., Perez T., et al. Pulmonary embolism in patients with unexplained exacerbation of chronic obstructive pulmonary disease: prevalence and risk factors. Ann Intern Med 2006, 144:390-396.
144. Stein P.D., Beemath A., Meyers F.A., et al. Pulmonary embolism and deep venous thrombosis in patients hospitalized with chronic obstructive pulmonary disease. J Cardiovasc Med 2007, 8:253-257.
145. Harvey R.L. Prevention of venous thromboembolism after stroke. Topics Stroke Rehab 2003, 10:61-69.
146. Skaf E., Stein P.D., Beemath A., et al. Venous thromboembolism in patients with ischemic and hemorrhagic stroke. Am J Cardiol 2005, 96:1731-1733.
147. Skaf E., Stein P.D., Beemath A., et al. Fatal pulmonary embolism and stroke. Am J Cardiol 2006, 97:1776-1777.
148. Dismuke S.E., VanderZwaag R. Accuracy and epidemiological implications of the death certificate diagnosis of pulmonary embolism. J Chronic Dis 1984, 37:67-73.
149. Stein P.D., Beemath A., Meyers F.A., et al. Incidence of venous thromboembolism in patients hospitalized with cancer. Am J Med 2006, 119:60-68.
150. Stein P.D., Beemath A., Meyers F.A., et al. Pulmonary embolism as a cause of death in patients who died with cancer. Am J Med 2006, 119:163-165.
151. Stein P.D., Hull R.D., Kayali F., et al. Venous thromboembolism in pregnancy: 21 year trends. Am J Med 2004, 117:121-125.
152. Anonymous Oral contraception and thrombo-embolic disease. J R Coll Gen Pract 1967, 13:267-279.
153. Rochat R.W., Koonin L.M., Atrash H.K., et al. Maternal mortality in the United States: report from the Maternal Mortality Collaborative. Obstet Gynecol 1988, 72:91-97.
154. Buehler J.W., Kaunitz A.M., Hogue C.J.R., et al. Maternal mortality in women aged 35 years or older: United States. JAMA 1986, 255:53-57.
155. Geerts W.H., Bergqvist D., Pineo G.F., et al. Preventive of venous thromboembolism. American College of Chest physicians evidence-based clinical practice guidelines (8th edition). Chest 2008, 133:381S-453.
156. Kroger K., Schelo C., Gocke C., et al. Colour Doppler sonographic diagnosis of upper limb venous thromboses. Clin Sci 1998, 94:657-661.
157. Timsit J.F., Farkas J.C., Boyer J.M., et al. Central vein catheter-related thrombosis in intensive care patients: incidence, risks factors, and relationship with catheter-related sepsis. Chest 1998, 114:207-213.
158. Haire W.D., Lieberman R.P., Edney J., et al. Hickman catheter-induced thoracic vein thrombosis. Frequency and long-term sequelae in patients receiving high-dose chemotherapy and marrow transplantation. Cancer 1990, 66:900-908.
159. Ryan J.A., Abel R.M., Abbott W.M., et al. Catheter complications in total parenteral nutrition. A prospective study of 200 consecutive patients. N Engl J Med 1974, 290:757-761.
160. Dollery C.M., Sullivan I.D., Bauraind O., et al. Thrombosis and embolism in long-term central venous access for parenteral nutrition. Lancet 1994, 344:1043-1045.
161. Mustafa S., Stein P.D., Patel K.C., et al. Upper extremity deep venous thrombosis. Chest 2003, 163:1213-1219.
162. Hingorani A., Ascher E., Lorenson E., et al. Upper extremity deep venous thrombosis and its impact on morbidity and mortality rates in a hospital-based population. J Vasc Surg 1997, 26:853-860.
163. Becker D.M., Philbrick T., Walker F.B.I.V. Axillary and subclavian venous thrombosis. Prognosis and treatment. Arch Intern Med 1991, 151:1934-1943.
164. Monreal M., Lafoz E., Ruiz J., et al. Upper-extremity deep venous thrombosis and pulmonary embolism. A prospective study. Chest 1991, 99:280-283.
165. Horattas M.C., Wright D.J., Fenton A.H., et al. Changing concepts of deep venous thrombosis of the upper extremity-report of a series and review of the literature. Surgery 1988, 104:561-567.
166. Joffe H.V., Kucher N., Tapson V.F., et al. Upper-extremity deep vein thrombosis: a prospective registry of 592 patients. Circulation 2004, 110:1605-1611.
167. Saleh T., Matta F., Yaekoub A.Y., et al. Risk of venous thromboembolism with inflammatory bowel disease. Clin Appl Thromb Hemost 2011, 17(3):254-258.
168. Saleh T, Matta F, Alali F, et al. Liver disease and risk of venous thromboembolism. Submitted for publication.
169. Søgaard K.K., Horváth-Puhó E., Grønbaek H., et al. Risk of venous thromboembolism in patients with liver disease: a nationwide population-based case-control study. Am J Gastroenterol 2009, 104:96-101.
170. Northup P.G., McMahon M.M., Ruhl A.P., et al. Coagulopathy does not fully protect hospitalized cirrhosis patients from peripheral venous thromboembolism. Am J Gastroenterol 2006, 101:1524-1528.
171. Tripodi A., Primignani M., Chantarangkul V., et al. An imbalance of pro- vs anti-coagulation factors in plasma from patients with cirrhosis. Gastroenterology 2009, 137:2105-2111.
172. Danescu L., Badshah A., Danescu S.C., et al. Venous thromboembolism in patients hospitalized with thyroid dysfunction. Clin Appl Thromb Hemost 2009, 15:676-680.
173. Seriolo B., Accardo S., Garnero A., et al. Anticardiolipin antibodies, free protein S levels and thrombosis: a survey in a selected population of rheumatoid arthritis patients. Rheumatology 1999, 38:675-678.
174. McEntegart A., Capell H.A., Creran D., et al. Cardiovascular risk factors, including thrombotic variables, in a population with rheumatoid arthritis. Rheumatology 2001, 40:640-644.
175. Matta F., Singala R., Yaekoub A.Y., et al. Risk of venous thromboembolism with rheumatoid arthritis. Thromb Haemost 2009, 101:134-138.
176. Stein P.D., Goldman J., Matta F., et al. Diabetes mellitus and risk of venous thromboembolism. Am J Med Sic 2009, 337:259-264.
177. Matta F., Yaekoub A.Y., Stein P.D. Human immunodeficiency virus infection and risk of venous thromboembolism. Am J Med Sci 2008, 336:402-406.
178. Kayali F., Najjar R., Aswad F., et al. Venous thromboembolism in patients hospitalized with nephrotic syndrome. Am J Med 2008, 121:226-230.
179. Stein P.D., Beemath A., Meyers F.A., et al. Deep venous thrombosis and pulmonary embolism in patients hospitalized with sickle cell disease. Am J Med 2006, 119:897-901.
180. Navarro S., Ricart J.M., Medina P., et al. Activated protein C levels in Behçet's disease and risk of venous thrombosis. Br J Haematol 2004, 126:550-556.
181. Gül A., Ozbek U., Oztürk C., et al. Coagulation factor V gene mutation increases the risk of venous thrombosis in behçet's disease. Br J Rheumatol 1996, 35:1178-1180.
182. Ray J.G., Burows R.F., Ginsberg J.S., et al. Paroxysmal nocturnal hemoglobinuria and the risk of venous thrombosis: review and recommendations for management of the pregnant and nonpregnant patient. Haemostasis 2000, 30:103-117.
183. Fischer M.D., Hopewell P.C. Recurrent pulmonary emboli and Buerger's disease. West J Med 1981, 135:238-241.